Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) EBITDA: 2016-2024

Historic EBITDA for ENDRA Life Sciences (NDRA) over the last 9 years, with Dec 2024 value amounting to -$10.8 million.

  • ENDRA Life Sciences' EBITDA fell 36.25% to -$3.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$11.5 million, marking a year-over-year increase of 0.03%. This contributed to the annual value of -$10.8 million for FY2024, which is 2.82% down from last year.
  • As of FY2024, ENDRA Life Sciences' EBITDA stood at -$10.8 million, which was down 2.82% from -$10.5 million recorded in FY2023.
  • ENDRA Life Sciences' EBITDA's 5-year high stood at -$10.5 million during FY2023, with a 5-year trough of -$13.2 million in FY2022.
  • Its 3-year average for EBITDA is -$11.5 million, with a median of -$10.8 million in 2024.
  • Its EBITDA has fluctuated over the past 5 years, first decreased by 14.43% in 2022, then climbed by 20.04% in 2023.
  • Over the past 5 years, ENDRA Life Sciences' EBITDA (Yearly) stood at -$11.5 million in 2020, then climbed by 0.03% to -$11.5 million in 2021, then fell by 14.43% to -$13.2 million in 2022, then grew by 20.04% to -$10.5 million in 2023, then declined by 2.82% to -$10.8 million in 2024.